PSA vs VKTX · rev $717.5M vs $3.97B cap
PSA (PSA) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported PSA revenue for 2019-12-31 was $717.5M. Net income was $387.1M. Revenue was up 3.6% from 2018-12-31 to 2019-12-31. PSA currently screens at market cap $0.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
PSA currently screens at market cap $0. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the PSA and VKTX stock pages for the full models.
Not investment advice.